Multiple functions of Cerberus cooperate to induce heart downstream of Nodal

Ann C Foley1, Oksana Korol, Anjuli M Timmer

  • 1Burnham Institute for Medical Research, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Developmental Biology
|November 25, 2006
PubMed

Insights

Nodal signaling induces heart development by activating Cerberus in endoderm, a pathway distinct from Wnt antagonists that activate Hex. Both pathways initiate cardiac mesoderm differentiation in overlying mesoderm.

Area of Science:

  • Developmental Biology
  • Molecular Signaling
  • Stem Cell Biology

Background:

  • Nodal signaling's role in heart induction is known, but its direct/indirect mechanisms and interactions remain unclear.
  • Previous studies implicated Nodal and its co-receptor Cripto in heart development using mouse models.
  • The precise molecular mediators and signaling pathways involved in Nodal-induced cardiogenesis require further elucidation.

Purpose of the Study:

  • To investigate the role of the DAN family protein Cerberus in Nodal-induced cardiogenesis.
  • To determine if Nodal signaling acts directly or indirectly to induce cardiac mesoderm.
  • To elucidate the relationship between Nodal/Cripto and Wnt antagonist pathways in heart development.

Main Methods:

  • Xenopus embryological studies.
  • Misexpression of Nodal homologue XNr1, Cripto, and constitutively active Alk4 (caAlk4).
  • Mosaic lineage tracing and morpholino-mediated knockdown of Cerberus and Hex.

Main Results:

  • Nodal signaling induces both cardiac markers and Cerberus in presumptive foregut endoderm.
  • Nodal/Cripto and caAlk4 induced cardiac markers cell non-autonomously, mediated by Cerberus.
  • Cerberus alone initiated cardiogenesis at a distance; its knockdown reduced cardiomyogenesis.
  • Nodal/Cripto and Wnt antagonists (Dkk1) induce cardiogenesis via distinct pathways involving Cerberus and Hex, respectively.

Conclusions:

  • Cardiogenesis depends on Nodal-mediated induction of Cerberus in endoderm.
  • This Nodal-Cerberus pathway is parallel to the Wnt antagonist-Hex pathway.
  • Both pathways in endoderm initiate cardiogenesis in overlying mesoderm.

Related Concept Videos

Conduction System of the Heart01:20

Conduction System of the Heart

The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...